Trinity Biotech (TRIB) Net Margin Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -10,757.00 |
| Sep 30, 2024 | -4,251.00 |
| Jun 30, 2024 | -7,949.00 |
| Mar 31, 2024 | -3,376.00 |
| Dec 31, 2023 | -5,319.00 |
| Sep 30, 2023 | -5,277.00 |
| Jun 30, 2023 | -14,801.00 |
| Mar 31, 2023 | -5,568.00 |
| Dec 31, 2022 | -7,031.00 |
| Sep 30, 2022 | -7,432.00 |
| Jun 30, 2022 | -1,255.00 |
| Mar 31, 2022 | -9,529.00 |
| Dec 31, 2021 | 16,546.00 |
| Sep 30, 2021 | 926.00 |
| Jun 30, 2021 | -900.00 |
| Mar 31, 2021 | 2,134.00 |
| Dec 31, 2020 | 1,850.00 |
| Sep 30, 2020 | -1,685.00 |
| Jun 30, 2020 | -196.00 |
| Mar 31, 2020 | -387.00 |
| Dec 31, 2019 | -891.00 |
| Sep 30, 2019 | -722.00 |
| Jun 30, 2019 | 1,728.00 |
| Mar 31, 2019 | -643.00 |
| Dec 31, 2018 | -776.00 |
| Sep 30, 2018 | -1,279.00 |
| Jun 30, 2018 | -840.00 |
| Mar 31, 2018 | -920.00 |
| Dec 31, 2017 | -2,165.00 |
| Sep 30, 2017 | -1,505.00 |
| Jun 30, 2017 | -1,361.00 |
| Mar 31, 2017 | -1,524.00 |
| Dec 31, 2016 | -20,947.00 |
| Sep 30, 2016 | -2,787.00 |
| Jun 30, 2016 | -1,757.00 |
| Mar 31, 2016 | -3,057.00 |
| Sep 30, 2015 | 5,337.00 |
| Jun 30, 2015 | -19,509.00 |
| Mar 31, 2015 | 542.00 |
| Dec 31, 2014 | 628.00 |
| Sep 30, 2014 | 602.00 |
| Jun 30, 2014 | 639.00 |
| Mar 31, 2014 | 889.00 |